Quais so
The primary reported issues are local: pain, redness, swelling, bruising, or, in rare cases, infection at the injection site if sterile technique is not followed
* Correspondence: Vishwanath Venketaraman, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Protocol 1: essential foundation (everyone should consider this) Goal: Prevent the most common nutrient deficiencies during GLP-1 therapy
Rhee CM, Ahmadi SF, Kovesdy CP, Kalantar-Zadeh K
Earlier this month, CBS News reported on a lawsuit a woman filed against the makers of popular weight-loss drugs Ozempic and Mounjaro, claiming the companies failed to adequately warn about the risk of severe gastrointestinal issues